High-throughput screening
A screen from a list of targets
Name the targets and the species: genes, long non-coding RNAs or microRNAs. AUM designs the sequences against each, makes them HPLC-purified in the chemistry you choose, and delivers them in tubes or plated with the controls included, priced per oligo, from 5 targets to 384.
Choose the target type, name the targets, choose how the panel is made, read the plate back, and send the request.
02 Species and gene list
An example, not your list
24 human genes, 3 sequences each, to show how a screen is laid out and priced.
From 5 to 384 genes, each checked against the mRNA index the search box uses: the official symbol, a previous symbol or an alias, in the species chosen. Typed, pasted, or from a file: one gene symbol per row, or the first column of a CSV. A file of up to 500 rows and 1 MB, as .txt, .csv or .tsv; a spreadsheet workbook is refused, so save it as CSV first.
24 genes: 0 resolved, 24 resolving.
| Row | Typed | Target | Status |
|---|---|---|---|
| 1 | TP53 | resolving | checking the index |
| 2 | EGFR | resolving | checking the index |
| 3 | KRAS | resolving | checking the index |
| 4 | BRAF | resolving | checking the index |
| 5 | MYC | resolving | checking the index |
| 6 | PTEN | resolving | checking the index |
| 7 | AKT1 | resolving | checking the index |
| 8 | PIK3CA | resolving | checking the index |
| 9 | CDK4 | resolving | checking the index |
| 10 | CDK6 | resolving | checking the index |
| 11 | CCND1 | resolving | checking the index |
| 12 | RB1 | resolving | checking the index |
| 13 | BRCA1 | resolving | checking the index |
| 14 | BRCA2 | resolving | checking the index |
| 15 | ATM | resolving | checking the index |
| 16 | MTOR | resolving | checking the index |
| 17 | CHEK1 | resolving | checking the index |
| 18 | CHEK2 | resolving | checking the index |
| 19 | MDM2 | resolving | checking the index |
| 20 | BCL2 | resolving | checking the index |
| 21 | BAX | resolving | checking the index |
| 22 | CASP3 | resolving | checking the index |
| 23 | STAT3 | resolving | checking the index |
| 24 | JUN | resolving | checking the index |
A screen starts at 5 genes. A shorter list, or one gene only, is a single-target order. The order page prices a single set of sequences.
04 Purification
HPLC, the purification every screening product is made in, in tubes and on plates alike: one grade for the whole screen.
07 Controls, included
On every plate the class's full set, in the last 3 wells of the fill order, at no charge, from the catalogue's own HPLC controls.
- Scramble controlAUM-SCR-B-10
- Positive controlAUM-POS-B-10
- Labeled scramble controlAUM-SCR-B-10-LAB-FAM
08 The plate, drawn
One 96-well plate · 31 genes each at 3 per gene, 3 control wells of a block of 3
A1: TP53, human, sequence 1 of 3
- gene, sequence number in the well
- control (S scramble, P positive, L labeled)
- spare
Filled down the columns from A1. 24 genes on this plate, room for 7 more, 21 spare wells. Arrow keys move between wells; Page Up and Page Down change the plate.
09 The manifest
Manifest, 75 rows: one per well or tube.
| Plate | Well | Type | Target | Species | Seq | Product |
|---|---|---|---|---|---|---|
| 1 | A1 | mRNA | TP53 | human | 1 | on quotation |
| 1 | B1 | mRNA | TP53 | human | 2 | on quotation |
| 1 | C1 | mRNA | TP53 | human | 3 | on quotation |
| 1 | D1 | mRNA | EGFR | human | 1 | on quotation |
| 1 | E1 | mRNA | EGFR | human | 2 | on quotation |
| 1 | F1 | mRNA | EGFR | human | 3 | on quotation |
| 1 | G1 | mRNA | KRAS | human | 1 | on quotation |
| 1 | H1 | mRNA | KRAS | human | 2 | on quotation |
| 1 | A2 | mRNA | KRAS | human | 3 | on quotation |
| 1 | B2 | mRNA | BRAF | human | 1 | on quotation |
| 1 | C2 | mRNA | BRAF | human | 2 | on quotation |
| 1 | D2 | mRNA | BRAF | human | 3 | on quotation |
| 1 | E2 | mRNA | MYC | human | 1 | on quotation |
| 1 | F2 | mRNA | MYC | human | 2 | on quotation |
| 1 | G2 | mRNA | MYC | human | 3 | on quotation |
| 1 | H2 | mRNA | PTEN | human | 1 | on quotation |
| 1 | A3 | mRNA | PTEN | human | 2 | on quotation |
| 1 | B3 | mRNA | PTEN | human | 3 | on quotation |
| 1 | C3 | mRNA | AKT1 | human | 1 | on quotation |
| 1 | D3 | mRNA | AKT1 | human | 2 | on quotation |
| 1 | E3 | mRNA | AKT1 | human | 3 | on quotation |
| 1 | F3 | mRNA | PIK3CA | human | 1 | on quotation |
| 1 | G3 | mRNA | PIK3CA | human | 2 | on quotation |
| 1 | H3 | mRNA | PIK3CA | human | 3 | on quotation |
| 1 | A4 | mRNA | CDK4 | human | 1 | on quotation |
| 1 | B4 | mRNA | CDK4 | human | 2 | on quotation |
| 1 | C4 | mRNA | CDK4 | human | 3 | on quotation |
| 1 | D4 | mRNA | CDK6 | human | 1 | on quotation |
| 1 | E4 | mRNA | CDK6 | human | 2 | on quotation |
| 1 | F4 | mRNA | CDK6 | human | 3 | on quotation |
| 1 | G4 | mRNA | CCND1 | human | 1 | on quotation |
| 1 | H4 | mRNA | CCND1 | human | 2 | on quotation |
| 1 | A5 | mRNA | CCND1 | human | 3 | on quotation |
| 1 | B5 | mRNA | RB1 | human | 1 | on quotation |
| 1 | C5 | mRNA | RB1 | human | 2 | on quotation |
| 1 | D5 | mRNA | RB1 | human | 3 | on quotation |
| 1 | E5 | mRNA | BRCA1 | human | 1 | on quotation |
| 1 | F5 | mRNA | BRCA1 | human | 2 | on quotation |
| 1 | G5 | mRNA | BRCA1 | human | 3 | on quotation |
| 1 | H5 | mRNA | BRCA2 | human | 1 | on quotation |
| 1 | A6 | mRNA | BRCA2 | human | 2 | on quotation |
| 1 | B6 | mRNA | BRCA2 | human | 3 | on quotation |
| 1 | C6 | mRNA | ATM | human | 1 | on quotation |
| 1 | D6 | mRNA | ATM | human | 2 | on quotation |
| 1 | E6 | mRNA | ATM | human | 3 | on quotation |
| 1 | F6 | mRNA | MTOR | human | 1 | on quotation |
| 1 | G6 | mRNA | MTOR | human | 2 | on quotation |
| 1 | H6 | mRNA | MTOR | human | 3 | on quotation |
Optional. 2,000 characters at most.
For research use only. Not for use in diagnostic or therapeutic procedures.
What a screen is
Many targets, one order
A screen is one order against many targets at once, and the target type is chosen first so that one product is never confused with another. A gene list becomes an mRNA screen with AUMsilence
Every self-delivering product needs no transfection reagent, in culture or in vivo; the transfection-optimized AUMsilence
Ordering
How it works
Step 1: Choose the target type: mRNA, long non-coding RNA or microRNA. Each door names the product designed against it, and the chemistries, the sequences per target and the controls follow from it.
Step 2: Paste or upload the list and choose the species. Every row is checked against the index the search box uses for that target type, and a row the index does not know is shown with the nearest names to pick from, never dropped; a microRNA named without its arm is offered the arms miRBase lists.
Step 3: Choose the chemistry, the sequences per target and the format: tubes, or, from 48 oligos, a 96-well or a 384-well plate, HPLC-purified either way and priced per oligo, with the full control set included on every plate and the scramble control in tubes.
Step 4: Read the plate back, well by well, and download the manifest: one row per well or tube with the target type, the target, the species, the sequence number and the product. Then send the request. Where the price list holds a screening record the price is computed from it and shown line by line; where it does not, the request goes to the team on quotation as it stands.
Applications
High-throughput screening applications
Target validation
Validate potential drug targets by screening gene families or pathway components simultaneously.
Pathway analysis
Dissect complex signaling pathways by knocking down multiple components in parallel.
Phenotypic screening
Identify genes involved in specific cellular phenotypes through systematic knockdown.
Disease modeling
Create disease models by targeting disease-associated gene sets identified from GWAS or transcriptomics.
Non-coding RNA panels
Inhibit a set of microRNAs, one antagomir each, or knock down a set of long non-coding RNAs, in one plate with its own controls.
Above 384 targets, or a genome-wide set
The page takes 5 to 384 targets in one request. For a larger set, or a screen designed with us, book a consultation or write to customer care.
For research use only. Not for use in diagnostic or therapeutic procedures.